1 - 25 of 108 results for author:"Tenen D.G." in Literature citations
Results Customize
› Repeat search in UniProtKB (18)
| Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells. Staber P.B., Zhang P., Ye M., Welner R.S., Nombela-Arrieta C., Bach C., Kerenyi M., Bartholdy B.A., Zhang H., Alberich-Jorda M. et al. Mol. Cell 49:934-946(2013) · Mapped (2) |
| Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Chen L., Li Y., Lin C.H., Chan T.H., Chow R.K., Song Y., Liu M., Yuan Y.F., Fu L., Kong K.L. et al. Nat. Med. 19:209-216(2013) · Mapped (3) |
| Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex. Gao C., Dimitrov T., Yong K.J., Tatetsu H., Jeong H.W., Luo H.R., Bradner J.E., Tenen D.G., Chai L. Blood 121:1413-1421(2013) · Mapped (2) |
| C/EBPgamma deregulation results in differentiation arrest in acute myeloid leukemia. Alberich-Jorda M., Wouters B., Balastik M., Shapiro-Koss C., Zhang H., Di Ruscio A., DiRuscio A., Radomska H.S., Ebralidze A.K., Amabile G. et al. J. Clin. Invest. 122:4490-4504(2012) · Mapped (1) |
| RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. Lichtinger M., Ingram R., Hannah R., Muller D., Clarke D., Assi S.A., Lie-A-Ling M., Noailles L., Vijayabaskar M.S., Wu M. et al. EMBO J. 31:4318-4333(2012) · Mapped (6) |
| C/EBPbeta promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion. Hayashi Y., Hirai H., Kamio N., Yao H., Yoshioka S., Miura Y., Ashihara E., Fujiyama Y., Tenen D.G., Maekawa T. Leukemia 27:619-628(2013) · Mapped (4) |
| Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells. Zhang Y., Yan X., Sashida G., Zhao X., Rao Y., Goyama S., Whitman S.P., Zorko N., Bernot K., Conway R.M. et al. Blood 120:1118-1129(2012) · Mapped (4) |
| C/EBPalpha and DEK coordinately regulate myeloid differentiation. Koleva R.I., Ficarro S.B., Radomska H.S., Carrasco-Alfonso M.J., Alberta J.A., Webber J.T., Luckey C.J., Marcucci G., Tenen D.G., Marto J.A. Blood 119:4878-4888(2012) · Mapped (6) |
| Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Ptasinska A., Assi S.A., Mannari D., James S.R., Williamson D., Dunne J., Hoogenkamp M., Wu M., Care M., McNeill H. et al. Leukemia 26:1829-1841(2012) · Mapped (8) |
| Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing. Basseres D.S., D'Alo F., Yeap B.Y., Lowenberg E.C., Gonzalez D.A., Yasuda H., Dayaram T., Kocher O.N., Godleski J.J., Richards W.G. et al. Lung Cancer 77:31-37(2012) · Mapped (3) |
| The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. Huang G., Zhao X., Wang L., Elf S., Xu H., Zhao X., Sashida G., Zhang Y., Liu Y., Lee J. et al. Blood 118:6544-6552(2011) · Mapped (9) |
| RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element. Levantini E., Lee S., Radomska H.S., Hetherington C.J., Alberich-Jorda M., Amabile G., Zhang P., Gonzalez D.A., Zhang J., Basseres D.S. et al. EMBO J. 30:4059-4070(2011) · Mapped (21) |
| DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. Luk J.M., Burchard J., Zhang C., Liu A.M., Wong K.F., Shek F.H., Lee N.P., Fan S.T., Poon R.T., Ivanovska I. et al. J. Biol. Chem. 286:30706-30713(2011) · Mapped (2) |
| CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis. Blanchet M.R., Bennett J.L., Gold M.J., Levantini E., Tenen D.G., Girard M., Cormier Y., McNagny K.M. Am. J. Respir. Crit. Care Med. 184:687-698(2011) · Mapped (5) |
| Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPalpha. Grandinetti K.B., Stevens T.A., Ha S., Salamone R.J., Walker J.R., Zhang J., Agarwalla S., Tenen D.G., Peters E.C., Reddy V.A. Oncogene 30:3328-3335(2011) · Mapped (4) |
| Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Leddin M., Perrod C., Hoogenkamp M., Ghani S., Assi S., Heinz S., Wilson N.K., Follows G., Schonheit J., Vockentanz L. et al. Blood 117:2827-2838(2011) · Mapped (6) |
| Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Jiang S., Alberich-Jorda M., Zagozdzon R., Parmar K., Fu Y., Mauch P., Banu N., Makriyannis A., Tenen D.G., Avraham S. et al. Blood 117:827-838(2011) · Mapped (8) |
| C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Pulikkan J.A., Peramangalam P.S., Dengler V., Ho P.A., Preudhomme C., Meshinchi S., Christopeit M., Nibourel O., Muller-Tidow C., Bohlander S.K. et al. Blood 116:5638-5649(2010) · Mapped (2) |
| CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. O'Brien K.B., Alberich-Jorda M., Yadav N., Kocher O., Diruscio A., Ebralidze A., Levantini E., Sng N.J., Bhasin M., Caron T. et al. Development 137:2147-2156(2010) · Mapped (84) |
| Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. Yeo W.L., Riely G.J., Yeap B.Y., Lau M.W., Warner J.L., Bodio K., Huberman M.S., Kris M.G., Tenen D.G., Pao W. et al. J Thorac Oncol 5:1048-1053(2010) · Mapped (19) |
| PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Aikawa Y., Katsumoto T., Zhang P., Shima H., Shino M., Terui K., Ito E., Ohno H., Stanley E.R., Singh H. et al. Nat. Med. 16:580-5, 1p following 2010:585-585(2010) · Mapped (22) |
| Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML. Pulikkan J.A., Dengler V., Peer Zada A.A., Kawasaki A., Geletu M., Pasalic Z., Bohlander S.K., Ryo A., Tenen D.G., Behre G. Leukemia 24:914-923(2010) · Mapped (4) |
| Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells. Will B., Siddiqi T., Jorda M.A., Shimamura T., Luptakova K., Staber P.B., Costa D.B., Steidl U., Tenen D.G., Kobayashi S. Blood 115:2901-2909(2010) · Mapped (9) |
| Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Pulikkan J.A., Dengler V., Peramangalam P.S., Peer Zada A.A., Muller-Tidow C., Bohlander S.K., Tenen D.G., Behre G. Blood 115:1768-1778(2010) · Mapped (2) |
| Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Guibal F.C., Alberich-Jorda M., Hirai H., Ebralidze A., Levantini E., Di Ruscio A., Zhang P., Santana-Lemos B.A., Neuberg D., Wagers A.J. et al. Blood 114:5415-5425(2009) · Mapped (2) |